Skip to main navigation Skip to search Skip to main content

Difference between the abilities of human Fcγ receptor-Expressing CV-1 cells to neutralize American and Asian Genotypes of dengue virus 2

  • W. W.I.S. Rodrigo
  • , D. C. Alcena
  • , Z. Kou
  • , T. J. Kochel
  • , K. R. Porter
  • , G. Comach
  • , R. C. Rose
  • , X. Jin
  • , J. J. Schlesinger

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

Sera from patients involved in a Peruvian outbreak of dengue virus serotype 1 infection cross-neutralized the American genotype of dengue virus serotype 2 up to 100-fold more efficiently than they did the virulent Asian genotype of dengue virus serotype 2, as determined by a plaque reduction neutralization test (PRNT) with CV-1 fibroblasts modified to express human Fcγ receptor CD32. The concordant preferential immune enhancement of the Asian genotype of dengue virus serotype 2 in human monocytes suggests that such a modification might strengthen the correlation between the PRNT titer and protection.

Original languageEnglish
Pages (from-to)285-287
Number of pages3
JournalClinical and Vaccine Immunology
Volume16
Issue number2
DOIs
StatePublished - Feb 2009

Fingerprint

Dive into the research topics of 'Difference between the abilities of human Fcγ receptor-Expressing CV-1 cells to neutralize American and Asian Genotypes of dengue virus 2'. Together they form a unique fingerprint.

Cite this